Literature DB >> 3021988

Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.

S F Cotmore, V C McKie, L J Anderson, C R Astell, P Tattersall.   

Abstract

Plasma from a child with homozygous sickle-cell disease, sampled during the early phase of an aplastic crisis, contained human parvovirus B19 virions. Plasma taken 10 days later (during the convalescent phase) contained both immunoglobulin M and immunoglobulin G antibodies directed against two viral polypeptides with apparent molecular weights of 83,000 and 58,000 which were present exclusively in the particulate fraction of the plasma taken during the acute phase. These two protein species comigrated at 110S on neutral sucrose velocity gradients with the B19 viral DNA and thus appear to constitute the viral capsid polypeptides. The B19 genome was molecularly cloned into a bacterial plasmid vector. Restriction endonuclease fragments of this cloned B19 genome were treated with BAL 31 and shotgun cloned into the open reading frame expression vector pJS413. Two expression constructs containing B19 sequences from different halves of the viral genome were obtained, which directed the synthesis, in bacteria, of segments of virally encoded protein. These polypeptide fragments were then purified and used to immunize rabbits. Antibodies against a protein sequence specified between nucleotides 2897 and 3749 recognized both the 83- and 58-kilodalton capsid polypeptides in aplastic plasma taken during the acute phase and detected similar proteins in the tissues of a stillborn fetus which had been infected transplacentally with B19. Antibodies against a protein sequence encoded in the other half of the B19 genome (nucleotides 1072 through 2044) did not react specifically with any protein in plasma taken during the acute phase but recognized three nonstructural polypeptides of 71, 63, and 52 kilodaltons present in the liver and, at lower levels, in some other tissues of the transplacentally infected fetus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021988      PMCID: PMC288924     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Parvovirus infections and hypoplastic crisis in sickle-cell anaemia.

Authors:  J R Pattison; S E Jones; J Hodgson; L R Davis; J M White; C E Stroud; L Murtaza
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent.

Authors:  M J Anderson; L R Davis; S E Jones; J R Pattison; G R Serjeant
Journal:  J Hyg (Lond)       Date:  1982-04

4.  An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D.

Authors:  J H Weis; L W Enquist; J S Salstrom; R J Watson
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.

Authors:  K R Rao; A R Patel; M J Anderson; J Hodgson; S E Jones; J R Pattison
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

6.  Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli.

Authors:  R J Watson; J H Weis; J S Salstrom; L W Enquist
Journal:  Science       Date:  1982-10-22       Impact factor: 47.728

7.  Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis.

Authors:  J F Kelleher; N L Luban; P P Mortimer; T Kamimura
Journal:  J Pediatr       Date:  1983-05       Impact factor: 4.406

8.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.

Authors:  P P Mortimer; R K Humphries; J G Moore; R H Purcell; N S Young
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

View more
  58 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

3.  Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

Authors:  H J O'Neill; P V Coyle
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

Authors:  H Sato; J Hirata; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.

Authors:  K Yoshimoto; S Rosenfeld; N Frickhofen; D Kennedy; R Hills; S Kajigaya; N S Young
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

8.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

9.  Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Authors:  Claudia Bönsch; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

Review 10.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.